Vanguard Fiduciary Trust
RVMD icon

Vanguard Fiduciary Trust’s Revolution Medicines RVMD Stock Holding History

Vanguard Fiduciary Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242M Buy
1,291,141
+157,822
+14% +$23.1M 0.05% 299
2026
Q1 		$110M Buy
+1,133,319
New +$114M 0.03% 476

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Fiduciary Trust's RVMD Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Revolution Medicines (RVMD) stake by 14% in Q2 2026, buying an estimated $23.1M and bringing the position to 1,291,141 shares worth $242M. The position accounts for 0.05% of the portfolio, ranked #299.

Vanguard Fiduciary Trust first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 686 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,291,141 shares of Revolution Medicines worth $242M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 157,822 Revolution Medicines shares in Q2 2026, an estimated $23.1M.
  • Revolution Medicines made up 0.05% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #299 holding.
  • Vanguard Fiduciary Trust first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 686 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.